Product
INCB018424/CC-4047
1 clinical trial
4 indications
Indication
Primary MyelofibrosisIndication
Juvenile Systemic SclerosisIndication
Post-Polycythemia Vera MyelofibrosisIndication
Post-ET MFClinical trial
A Phase-Ib/II Study of Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MyelofibrosisStatus: Active (not recruiting), Estimated PCD: 2024-04-01